▲ NIFTY 50 top gainers HDFCLIFE₹557.00▲ 5.05% TMPV₹314.50▲ 4.49% SBILIFE₹1,766.90▲ 4.06% DRREDDY₹1,175.00▲ 3.07% BEL₹395.45▲ 2.51% INDIGO₹4,845.00▲ 2.36% TATASTEEL₹187.29▲ 2.34% JIOFIN₹229.30▲ 1.98% ETERNAL₹322.35▲ 1.69% SHRIRAMFIN₹995.00▲ 1.63% ▼ NIFTY 50 top losers ONGC₹232.43▼ 1.85% TITAN₹4,841.00▼ 1.38% HDFCBANK₹713.00▼ 1.18% COALINDIA₹418.00▼ 1.01% HINDUNILVR₹1,942.20▼ 1.01% NESTLEIND₹1,370.60▼ 1.00% ICICIBANK₹1,347.60▼ 0.82% BAJAJ-AUTO₹11,500.00▼ 0.80% GRASIM₹3,173.10▼ 0.44% WIPRO₹166.40▼ 0.29% NSE most active PNB₹116.47▼ 0.28% ITC₹266.20▲ 0.78% KOTAKBANK₹416.50▲ 0.36% CANBK₹123.90▲ 0.57%

NSE MAXHEALTH · BSE 543220 · Healthcare Facilities · NIFTY 50

Max Healthcare Institute Share Price

Market open · updated 25 Sep, 2:18 PM IST
₹1,048.80 ▼ −₹6.01 · 0.57% NSE · as of 24 Sep 2026, 8:55 AM · BSE ₹1,046.60
Today's range
₹1,029.20Low₹1,055.95High
52-week range
₹903.50Low · 7 Apr 2026₹1,221.10High · 23 Oct 2025

Max Healthcare Institute Overview

Where the price stands, how it has moved and how it sits against its averages.

Max Healthcare Institute shares last traded at ₹1,048.80 on the NSE, down 0.57% on the day. That is 14.1% below the 52-week high of ₹1,221.10 and 16.1% above the 52-week low of ₹903.50. The stock trades at 75.28× earnings, above the sector average of 30.42. Its market value is ₹1,01,867 Cr.

Price returns

1 Day▼ −0.57%
5 Days▲ +3.40%
This month▲ +1.71%
3 Months▼ −2.02%
6 Months▲ +7.26%
This year▲ +1.42%
1 Year▼ −8.39%

Against the market: 1 Month ▲ +9.19% · 3 Months ▲ +0.82% · 6 Months ▲ +7.89% · This year ▲ +15.50% · 1 Year ▲ +0.51%

Shading grows with the size of the move. Prices refresh every 15 minutes while the market is open (9:15 AM–3:30 PM IST).

Moving averages — price is above 6 of 6

  1. Today's price₹1,048.80
  2. 50-day average₹1,047.08 ▲ price 0.2% above
  3. 5-day average₹1,046.88 ▲ price 0.2% above
  4. 100-day average₹1,046.87 ▲ price 0.2% above
  5. 300-day average₹1,038.15 ▲ price 1.0% above
  6. 10-day average₹1,037.12 ▲ price 1.1% above
  7. 20-day average₹1,021.31 ▲ price 2.7% above

Averages above today's price sit higher on the ladder. Price above most of its averages is usually read as an upward trend.

Max Healthcare Institute Financial Results

Revenue and net profit in ₹ crore, with the full statements underneath.

Revenue₹ crore
8,373
Net profit₹ crore · losses below zero
−138
1,442

Year by year

Fiscal yearRevenueGrowthNet profitNet marginEPSDividend
FY 2026 ₹8,373 Cr ▲ +19.1% ₹1,442 Cr 17.2% ₹14.83 ₹2.00
FY 2025 ₹7,028 Cr ▲ +30.0% ₹1,076 Cr 15.3% ₹11.01 ₹1.50
FY 2024 ₹5,406 Cr ▲ +18.5% ₹1,058 Cr 19.6% ₹10.84 ₹1.50
FY 2023 ₹4,563 Cr ▲ +16.1% ₹1,104 Cr 24.2% ₹11.36 ₹1.00
FY 2022 ₹3,931 Cr ▲ +57.0% ₹605 Cr 15.4% ₹6.24 —
FY 2021 ₹2,505 Cr ▲ +32.9% −₹138 Cr −5.5% −₹1.59 —
FY 2020 ₹1,884 Cr — ₹95 Cr 5.1% ₹1.05 ₹0.00

Balance sheet — FY26

Owes (liabilities)Shareholders' equity
38%
62%
  • Total assets₹17,231 Cr
  • Total liabilities₹6,484 Cr
  • Shareholders' equity₹10,747 Cr
  • Total debt₹3,478 Cr
  • Cash & investments₹666 Cr
  • Current ratio0.89×
  • Revenue growth, 5 yr27.30% a year
  • Operating margin (TTM)20.62%
  • Net margin (TTM)16.73%

Cash flow — FY26

Operating activities
▲ ₹1,633 Cr
Investing activities
▼ −₹1,689 Cr
Financing activities
▲ ₹59 Cr
Free cash flow
▲ ₹149 Cr
Net change in cash
▲ ₹4 Cr

Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.

Full financial statements, FY20–FY26
₹ croreFY20FY21FY22FY23FY24FY25FY26
Total revenue1,884.462,504.673,931.464,562.605,406.027,028.468,373.45
Cost of revenue430.71645.78985.57990.931,196.061,592.082,033.30
Gross profit1,453.751,858.892,945.893,571.674,209.965,436.386,340.15
Operating expenses1,714.582,508.363,200.683,551.054,146.865,585.766,590.65
Operating income169.88−3.69730.781,011.551,259.161,442.701,782.80
Depreciation119.74174.09221.12232.19244.92358.87446.53
Profit before tax89.08−68.65738.901,063.721,365.321,406.371,675.58
Tax−6.2645.85133.85−39.79307.68330.49233.17
Net profit95.34−137.55605.051,103.511,057.641,075.881,442.41
EPS (₹)1.05−1.596.2411.3610.8411.0114.83
Dividend per share (₹)0.00——1.001.501.502.00

What Analysts Say

24 analysts

Recommendations from 24 analysts who cover Max Healthcare Institute.

Buy average rating 2.13 on a 1–5 scale

▲ 18 bullish (75.0%) · 2 hold (8.3%) · ▼ 4 bearish (16.7%)

Votes

Strong Buy
7 (29%)
Buy
11 (46%)
Hold
2 (8%)
Sell
4 (17%)
Strong Sell
0 (0%)

How the votes changed

Rating3M ago2M ago1M ago1W agoNow3-month change
Strong Buy66777 ▲ +1
Buy1112121111 —
Hold23222 —
Sell44444 —
Strong Sell00000 —

Analyst ratings are opinions, not a guarantee of returns.

Max Healthcare Institute vs Peers

Side by side with other healthcare facilities companies. The small bars compare each column.

CompanyPriceChangeMarket capP/EP/BROE (5 yr)Net marginDiv. yieldRating
Max Healthcare Institute ₹1,048.80 ▼ −0.57% ₹1,01,867 Cr 75.28 9.60 13.32% 16.73% 0.19% This stock
Apollo Hospitals Enterprise ₹8,940.00 ▼ −1.33% ₹1,28,543 Cr 64.93 13.39 18.12% 7.76% 0.23% Bullish
Fortis Healthcare ₹883.00 ▼ −0.90% ₹66,663 Cr 67.89 7.27 9.36% 11.66% 0.10% Bearish
Aster DM Healthcare ₹767.80 ▲ +0.95% ₹67,011 Cr 102.55 9.26 7.13% 9.20% 0.49% Neutral
Narayana Hrudayalaya ₹1,882.80 ▼ −2.02% ₹38,397 Cr 48.07 9.08 25.72% 10.26% 0.22% Moderately Bearish
Global Health ₹1,510.00 ▲ +0.97% ₹40,762 Cr 63.65 8.93 15.69% 12.56% 0.04% Bullish

Rating = the data provider's overall technical view of each peer. Company names link to their own pages.

Shareholding Pattern

Who owns Max Healthcare Institute shares, quarter by quarter (latest on top).

PromoterFIIMFOther
Jun '26
23.7%
41.8%
18.7%
15.8%
Mar '26
Dec '25
Sep '25
HolderSep '25Dec '25Mar '26Jun '26Change
Promoter23.74%23.72%23.71%23.71% 0.00 pts
FII51.80%50.55%45.39%41.78% ▼ −3.61 pts
MF14.25%14.04%16.30%18.68% ▲ +2.38 pts
Other10.21%11.69%14.60%15.83% ▲ +1.23 pts

Max Healthcare Institute Key Metrics

Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.

Max Healthcare InstituteBenchmarkComfortable → stretched

Valuation Is the price reasonable?

P/E (TTM)Price ÷ yearly earnings per share
75.28
▲ 147% above the sector average of 30.42
P/E, 12-month rangeLow 38.87 · high 109.39
52%
Today's P/E sits 52% of the way from its low to its high
P/BPrice ÷ book value per share
9.60
P/SPrice ÷ sales per share
11.84
P/CFPrice ÷ cash flow per share
53.41
PEGP/E ÷ earnings growth (≈1 is fair)
7.60

Profitability Of every ₹100 of sales, how much is kept?

Gross marginKept after the cost of goods
78.67%
▲ above its 5-yr average of 76.80%
Operating marginKept after running costs
20.62%
▼ below its 5-yr average of 21.25%
Pre-tax marginKept before tax
19.64%
▼ below its 5-yr average of 21.33%
Net marginKept as profit
16.73%
▼ below its 5-yr average of 18.03%

Returns & efficiency How well does it use its money?

Return on equityProfit on shareholders' money
14.33%
▲ above its 5-yr average of 13.32%
Return on assetsProfit on everything it owns
8.89%
▼ below its 5-yr average of 8.90%
Return on investmentProfit on long-term capital
10.14%
▲ above its 5-yr average of 9.96%

Growth Is the business getting bigger?

Revenue — last 12 months
+16.0%
▲ growing
Revenue — 3 yr, a year
+22.4%
▲ growing
Revenue — 5 yr, a year
+27.3%
▲ growing (off the scale)
EPS — last 12 months
+27.6%
▲ growing (off the scale)
EPS — 3 yr, a year
+9.3%
▲ growing
Dividend — 3 yr, a year
+26.0%
▲ growing (off the scale)
Book value — 5 yr, a year
+13.6%
▲ growing

Financial strength Can it pay its bills and debts?

Debt to equityBorrowings for every ₹1 of shareholders' money
0.32×
✓ Low debt
Current ratioShort-term assets for every ₹1 due within a year
0.89×
! Tight
Quick ratioLike the current ratio, without inventory
0.84×
• Adequate
Interest coverOperating profit ÷ interest to pay
16.05×
✓ Strong
Payout ratioShare of profit paid as dividend
13.49%
• Keeps most

Per share What each share stands for

EPS (TTM)
₹14.98
Book value
₹110.44
Cash flow
₹19.87
Dividend
₹2.00
Revenue
₹89.62

The share price is 9.50× the book value behind each share.

Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.

All 108 metrics from the data provider

Valuation

P/E excluding extraordinary items, most recent fiscal year71.46
Current Dividend Yield - Common Stock Primary Issue, LTM0.19
Price to Book - most recent fiscal year9.60
P/E Basic excluding extraordinary items - TTM75.28
P/E including extraordinary items - TTM70.75
P/E excluding extraordinary items low, trailing 12 months38.87
Price to Tangible Book - most fiscal year21.77
Price to sales - most recent fiscal year12.32
Dividend Yield - indicated annual dividend divided by closing price0.19
Price to Cash Flow per share - trailing 12 month53.41
Peg Ratio7.60
Price to Free Cash Flow per Share - most recent fiscal year32,542.95
P/E Normalized, most recent fiscal year69.50
P/E excluding extraordinary items high, trailing 12 months109.39
P/E excluding extraordinary items, most recent fiscal year quarter70.75
Price to sales - trailing 12 month11.84
Net Debt, LFY28,125.60

Per share

Cash Flow per share - trailing 12 month19.87
Cash Flow per share - most recent fiscal year19.42
EPS including extraordinary items - trailing 12 month14.98
EPS including extraordinary items - most recent fiscal year14.83
EBITD per share - trailing 12 month23.85
Revenue/share - trailing 12 month89.62
EPS excluding extraordinary items - trailing 12 month14.98
EPS Basic excluding extraordinary items - most recent fiscal year14.83
EPS Basic excluding extraordinary items - trailing 12 month15.00
Book value per share - most recent fiscal year110.43
Dividend per share - most recent fiscal year2.00
Revenue/share - most recent fiscal year86.11
EPS Normalized - most recent fiscal year15.25
Book value (tangible) per share - most recent fiscal year48.70
Dividends per share - trailing 12 month2.00
EPS excluding extraordinary items - most recent fiscal year14.83
Cash per share - most recent fiscal year6.84

Margins

Operating margin - trailing 12 month20.62
Gross Margin - 5 year average76.80
Operating margin - 1st historical fiscal year21.29
Operating Margin - 5 year average21.25
Net Profit Margin % - 1st historical fiscal year17.23
Gross Margin - 1st historical fiscal year75.72
Net Profit Margin % - trailing 12 month16.73
Net Profit Margin - 5 year average18.03
Pretax Margin - 5 year average21.33
Pretax margin - 1st historical fiscal year20.01
Pretax margin - trailing 12 month19.64
Free Operating Cash Flow/Revenue, 5 Year Average5.81
Gross Margin - trailing 12 month78.67

Growth

EPS Change %, TTM over TTM27.62
Revenue growth rate, 5 year27.30
Revenue Change % - most recent quarter 1 year ago16.70
Growth rate% - dividend, 3 year25.99
Growth rate% - EPS, 3 year9.31
Revenue/share (5 yr growth)24.30
Free Operating Cash Flow, 5 Year CAGR−59.15
Tangible Book Value, Total Equity, 5 Year CAGR41.00
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR28.57
Capital Spending growth rate, 5 year65.82
Revenue Change %, TTM over TTM15.96
Growth rate% - Revenue, 3 year22.43
Book value per share growth rate, 5 year13.60
EPS Change % - most recent quarter 1 year ago4.76
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR41.31
Total Debt, 5 Year CAGR25.86

Financial strength

Net Interest coverage - most recent fiscal year16.05
Free Cash Flow - most recent fiscal year31.70
LT debt/equity - most recent fiscal year0.28
Quick ratio - most recent fiscal year0.84
Payout ratio - trailing 12 month13.36
Current ratio - most recent fiscal year0.89
Current EV/Free Cash Flow, LFY409.50
Total debt/total equity - most recent fiscal year0.32
Net Interest coverage - trailing 12 month7.34
Payout ratio - most recent fiscal year13.49

Returns & efficiency

Return on average equity - 5 year average13.32
Net Income/employee - trailing 12 month8,92,249.30
Revenue/employee - most recent fiscal year53,25,267.00
Return on investment - most recent fiscal year10.14
Return on average assets - most recent fiscal year8.89
Receivables turnover - most recent fiscal year9.47
Inventory turnover - most recent fiscal year18.44
Revenue/employee - trailing 12 month53,33,691.00
Return on average assets - 5 year average8.90
Net Income/employee - most recent fiscal year9,17,330.20
Asset turnover - most recent fiscal year0.52
Return on average equity - most recent fiscal year14.33
Return on investment - 5 year average9.96

Price & volume

Market Cap1,01,866.65
52 week Low Date7 Apr 2026
Price - 1 Day % Change0.32
Relative (S&P500) price percent change - 13 week0.82
Avg trading volume last 10 days2.06
Price - 13 week price percent change−2.02
Price - 52 week price percent change−8.39
Avg Trading Volume Last 3 months40.07
Price - 5 Day % Change3.40
Price % Change Month To Date1.71
Relative (S&P500) price percent change - 04 week9.19
52 week High Date23 Oct 2025
Price - 26 week price percent change7.26
PDATE23 Sep 2026
Price - YTD price percent change1.42
Relative (S&P500) price percent change - 52 week0.51
NPRICE1,059.90
Relative (S&P500) price percent change - 26 week7.89
52 week Low903.00
52 week High1,221.90
Beta0.86
Relative (S&P500) price percent change - Year to Date15.50

Dividends & Corporate Events

Payouts to shareholders, splits and bonus issues, and company meetings — newest first.

Dividend per share₹ per share, by fiscal year
₹2.00
  • Dividend yield0.19%
  • Payout ratio13.49%
  • Latest dividend₹2.00 per share · 3 Jul 2026

Corporate calendar

  • BoardQuarterly Results
  • MeetingAnnual General Meeting
  • Dividend₹2.00 per share · 20% · Final dividend
  • BoardAudited Results & Final Dividend
  • MeetingPostal Ballot
  • BoardQuarterly Results
  • BoardQuarterly Results
  • BoardQuarterly Results
Show 9 older events
  • MeetingAnnual General Meeting
  • BoardAudited Results & Final Dividend
  • BoardQuarterly Results
  • BoardQuarterly Results
  • MeetingAnnual General Meeting
  • Dividend₹1.50 per share · 15% · Final dividend
  • MeetingAnnual General Meeting
  • Dividend₹1.00 per share · 10% · Final dividend
  • MeetingPostal Ballot

About Max Healthcare Institute

Healthcare Facilities

Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company offers an integrated suite of diagnostics and lab services, ambulatory care, consultations, surgical and non-surgical procedures, and medical treatment. Its clinical offerings span a range of therapeutic areas, including radiation therapy for cancer, and specialized treatments in oncology, neurosciences, cardiac sciences, orthopedics, renal and liver care and minimally invasive surgery. It also provides consultations across diverse medical specialties such as diabetes and endocrinology, pulmonology, nephrology, dermatology, gastroenterology, physiotherapy and rehabilitation. It also caters to specific healthcare needs, including transplant services, audiology and speech therapy, and dedicated pediatric care. It offers a home care program through Max@Home, enabling patients to receive medical attention in the comfort of their homes. Its Max Lab provides at-home diagnostic testing.

Key people

  • Abhay SoiExecutive Chairman of the Board, Managing Director
  • Yogesh Kumar SareenChief Financial Officer, Senior Director
  • Umesh GuptaChief Human Resources Officer, Senior Director - Human Resources
  • Dhiraj AroraaSenior Vice President - Compliance Officer, Company Secretary
  • D.N. Suresh KumarSenior Vice President - Infrastructure
  • Sachin KumarSenior Vice President - Internal Audit

Company facts

  • NSE symbolMAXHEALTH
  • BSE code543220
  • ISININE027H01010
  • IndustryHealthcare Facilities
  • IndexNIFTY 50, NIFTY 500
  • Market cap₹1,01,867 Cr
  • Revenue (FY26)₹8,373 Cr
  • Net profit (FY26)₹1,442 Cr

In the News

Recent headlines about Max Healthcare Institute — they open on Mint in a new tab.

Stock data comes from the exchange feed via our data provider and may be delayed. It is for information only and is not a recommendation to buy or sell. See all stocks →

Frequently Asked Questions

Max Healthcare Institute (NSE: MAXHEALTH) last traded at ₹1,048.80 on the NSE, down 0.57% (₹6.01) on the day, as of 24 Sep 2026, 8:55 AM. On the BSE it was ₹1,046.60. The day's range was ₹1,029.20 – ₹1,055.95.

Max Healthcare Institute's 52-week high is ₹1,221.10 (23 Oct 2025) and its 52-week low is ₹903.50 (7 Apr 2026). At ₹1,048.80 the share is 14.1% below its high and 16.1% above its low.

Max Healthcare Institute's market capitalisation is ₹1,01,867 Cr (₹1.02L Cr). It is part of the NIFTY 50 index.

Max Healthcare Institute's P/E ratio (trailing 12 months) is 75.28. The sector average is 30.42, so investors pay 147% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹14.98.

Max Healthcare Institute shares are down 8.39% over the last year, up 1.42% so far this year, up 7.26% over 6 months, down 2.02% over 3 months. Over the last year the stock did 0.51% better than the market.

In FY26 (year to Mar 2026), Max Healthcare Institute reported revenue of ₹8,373 Cr (up 19.14% on the year before) and a net profit of ₹1,442 Cr. Earnings per share were ₹14.83.

Yes. Max Healthcare Institute's latest dividend is ₹2.00 per share (20%, final dividend), with an ex-date of 3 Jul 2026. The dividend yield is 0.19%. It has paid 3 dividends in the records shown on this page.

Of 24 analysts covering Max Healthcare Institute, 18 are bullish (7 strong buy, 11 buy), 2 say hold and 4 are bearish. The consensus is Buy (average rating 2.13 on a scale where 1 is Strong Buy and 5 is Strong Sell). Analyst views are opinions, not a guarantee.

As of Jun 2026: Promoter 23.71%, FII 41.78%, MF 18.68%, Other 15.83%.

Max Healthcare Institute's listed peers in Healthcare Facilities include Apollo Hospitals Enterprise, Fortis Healthcare, Aster DM Healthcare, Narayana Hrudayalaya, Global Health. By market capitalisation it ranks #2 of 6 in this group.